Results
|
6681.
|
|
|
6682.
|
Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status. [electronic resource] by
- Kang, Myoung Joo
- Hong, Yong Sang
- Kim, Kyu-pyo
- Kim, Sun Young
- Baek, Ji Yeon
- Ryu, Min-Hee
- Lee, Jae-Lyun
- Chang, Heung Moon
- Kim, Mi-Jung
- Chang, Hee Jin
- Kang, Yoon-Koo
- Kim, Tae Won
Producer: 20121029
In:
Investigational new drugs vol. 30
Availability: No items available.
|
|
6683.
|
Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. [electronic resource] by
- Viganò, Luca
- Capussotti, Lorenzo
- Barroso, Eduardo
- Nuzzo, Gennaro
- Laurent, Christophe
- Ijzermans, Jan N M
- Gigot, Jean-François
- Figueras, Joan
- Gruenberger, Thomas
- Mirza, Darius F
- Elias, Dominique
- Poston, Graeme
- Letoublon, Christian
- Isoniemi, Helena
- Herrera, Javier
- Sousa, Francisco Castro
- Pardo, Fernando
- Lucidi, Valerio
- Popescu, Irinel
- Adam, René
Producer: 20130319
In:
Annals of surgical oncology vol. 19
Availability: No items available.
|
|
6684.
|
|
|
6685.
|
[Evaluation of ADC mapping as an early predictor for tumor response to chemotherapy in recurrent glioma treated with bevacizumab/irinotecan: proof of principle]. [electronic resource] by
- Ringelstein, A
- Turowski, B
- Gizewski, E R
- Schroeteler, J
- Rapp, M
- Saleh, A
- Lanzman, R S
- Mathys, C
- Sabel, M
- Mödder, U
Producer: 20101022
In:
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin vol. 182
Availability: No items available.
|
|
6686.
|
|
|
6687.
|
|
|
6688.
|
|
|
6689.
|
Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1. [electronic resource] by
- Jonchère, Barbara
- Vétillard, Alexandra
- Toutain, Bertrand
- Lam, David
- Bernard, Anne Charlotte
- Henry, Cécile
- De Carné Trécesson, Sophie
- Gamelin, Erick
- Juin, Philippe
- Guette, Catherine
- Coqueret, Olivier
Producer: 20160119
In:
Oncotarget vol. 6
Availability: No items available.
|
|
6690.
|
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. [electronic resource] by
- Ferrone, Cristina R
- Marchegiani, Giovanni
- Hong, Theodore S
- Ryan, David P
- Deshpande, Vikram
- McDonnell, Erin I
- Sabbatino, Francesco
- Santos, Daniela Dias
- Allen, Jill N
- Blaszkowsky, Lawrence S
- Clark, Jeffrey W
- Faris, Jason E
- Goyal, Lipika
- Kwak, Eunice L
- Murphy, Janet E
- Ting, David T
- Wo, Jennifer Y
- Zhu, Andrew X
- Warshaw, Andrew L
- Lillemoe, Keith D
- Fernández-del Castillo, Carlos
Producer: 20150406
In:
Annals of surgery vol. 261
Availability: No items available.
|
|
6691.
|
|
|
6692.
|
|
|
6693.
|
Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer. [electronic resource] by
- Morris, Van
- Overman, Michael J
- Jiang, Zhi-Qin
- Garrett, Christopher
- Agarwal, Shweta
- Eng, Cathy
- Kee, Bryan
- Fogelman, David
- Dasari, Arvind
- Wolff, Robert
- Maru, Dipen
- Kopetz, Scott
Producer: 20150518
In:
Clinical colorectal cancer vol. 13
Availability: No items available.
|
|
6694.
|
|
|
6695.
|
|
|
6696.
|
|
|
6697.
|
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab. [electronic resource] by
- Demurtas, Laura
- Puzzoni, Marco
- Giampieri, Riccardo
- Ziranu, Pina
- Pusceddu, Valeria
- Mandolesi, Alessandra
- Cremolini, Chiara
- Masi, Gianluca
- Gelsomino, Fabio
- Antoniotti, Carlotta
- Loretelli, Cristian
- Meriggi, Fausto
- Zaniboni, Alberto
- Falcone, Alfredo
- Cascinu, Stefano
- Scartozzi, Mario
Producer: 20170907
In:
British journal of cancer vol. 117
Availability: No items available.
|
|
6698.
|
|
|
6699.
|
HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors. [electronic resource] by
- Proia, David A
- Smith, Donald L
- Zhang, Junyi
- Jimenez, John-Paul
- Sang, Jim
- Ogawa, Luisa Shin
- Sequeira, Manuel
- Acquaviva, Jaime
- He, Suqin
- Zhang, Chaohua
- Khazak, Vladimir
- Astsaturov, Igor
- Inoue, Takayo
- Tatsuta, Noriaki
- Osman, Sami
- Bates, Richard C
- Chimmanamada, Dinesh
- Ying, Weiwen
Producer: 20160906
In:
Molecular cancer therapeutics vol. 14
Availability: No items available.
|
|
6700.
|
Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 study. [electronic resource] by
- Tolcher, Anthony W
- LoRusso, Patricia
- Arzt, Jennifer
- Busman, Todd A
- Lian, Guinan
- Rudersdorf, Niki S
- Vanderwal, Carol Ann
- Waring, Jeffrey F
- Yang, Jianning
- Holen, Kyle D
- Rosen, Lee S
Producer: 20160128
In:
Cancer chemotherapy and pharmacology vol. 76
Availability: No items available.
|